This research report examines midsize biopharma and medical device executives' current outlooks on real-world data utilization.
As more biopharma and medical device companies start to engage with a variety of new datasets, the trends surrounding data uptake are rapidly changing. To understand more, we surveyed 150 executives from small and midsize biopharma and medical device companies on their perspectives surrounding real-world data (RWD).
This survey report examines our findings and details the data sources that are predicted to become a more (or less) valuable part of the broader RWD ecosystem. Read now to learn more about:
Offered Free by: BioPharma Dive's studioID and Merative
See All Resources from: BioPharma Dive's studioID and Merative